A Synthetic Protocell-Based Heparin Scavenger.
暂无分享,去创建一个
[1] S. Mann,et al. Triggerable Protocell Capture in Nanoparticle-Caged Coacervate Microdroplets , 2022, Journal of the American Chemical Society.
[2] D. Qiu,et al. A three-tiered colloidosomal microreactor for continuous flow catalysis , 2021, Nature Communications.
[3] M. Kostiainen,et al. Polyelectrolyte Encapsulation and Confinement within Protein Cage-Inspired Nanocompartments , 2021, Pharmaceutics.
[4] Yan Qiao,et al. Directing Transition of Synthetic Protocell Models via Physicochemical Cues‐Triggered Interfacial Dynamic Covalent Chemistry , 2021, Advanced science.
[5] Jianzhong Wu,et al. Membrane-confined liquid-liquid phase separation toward artificial organelles , 2021, Science Advances.
[6] Zhuojun Meng,et al. Cationic cellulose nanocrystals for fast, efficient and selective heparin recovery , 2021 .
[7] J. V. van Hest,et al. Engineering of Biocompatible Coacervate-Based Synthetic Cells , 2021, ACS applied materials & interfaces.
[8] Kemin Wang,et al. Enzyme-mediated nitric oxide production in vasoactive erythrocyte membrane-enclosed coacervate protocells , 2020, Nature Chemistry.
[9] D. Hilvert,et al. Two-tier supramolecular encapsulation of small molecules in a protein cage , 2020, Nature Communications.
[10] Yuval Elani,et al. Interfacing Living and Synthetic Cells as an Emerging Frontier in Synthetic Biology , 2020, Angewandte Chemie.
[11] Stephen Mann,et al. Light-Activated Signaling in DNA-Encoded Sender–Receiver Architectures , 2020, bioRxiv.
[12] M. Nowakowska,et al. Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats , 2020, The Journal of Pharmacology and Experimental Therapeutics.
[13] L. Gurevich,et al. Drug Delivery with Polymeric Nanocarriers—Cellular Uptake Mechanisms , 2020, Materials.
[14] V. Linko,et al. Serum Albumin–Peptide Conjugates for Simultaneous Heparin Binding and Detection , 2019, ACS omega.
[15] S. Mann,et al. Response-retaliation behaviour in synthetic protocell communities. , 2019, Angewandte Chemie.
[16] S. Mann,et al. Spatial Positioning and Chemical Coupling in Coacervate‐in‐Proteinosome Protocells , 2019, Angewandte Chemie.
[17] A. Patil,et al. Modulation of Higher‐order Behaviour in Model Protocell Communities by Artificial Phagocytosis , 2019, Angewandte Chemie.
[18] Stephen Mann,et al. DNA-based Communication in Populations of Synthetic Protocells , 2019, Nature Nanotechnology.
[19] J. V. van Hest,et al. Feedback-Induced Temporal Control of “Breathing” Polymersomes To Create Self-Adaptive Nanoreactors , 2018, Journal of the American Chemical Society.
[20] Stephen Mann,et al. Predatory behaviour in synthetic protocell communities. , 2017, Nature chemistry.
[21] O. Rojas,et al. Effect of PEG-PDMAEMA Block Copolymer Architecture on Polyelectrolyte Complex Formation with Heparin. , 2016, Biomacromolecules.
[22] R. Linhardt,et al. Heparin: Past, Present, and Future , 2016, Pharmaceuticals.
[23] B. Kalaska,et al. The toxicology of heparin reversal with protamine: past, present and future , 2016, Expert opinion on drug metabolism & toxicology.
[24] Christopher M. Jakobson,et al. Influence of Electrostatics on Small Molecule Flux through a Protein Nanoreactor. , 2015, ACS synthetic biology.
[25] J. Bereta,et al. Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin , 2015, PloS one.
[26] A. Patil,et al. Design and construction of higher-order structure and function in proteinosome-based protocells. , 2014, Journal of the American Chemical Society.
[27] David K. Smith,et al. Heparin sensing and binding - taking supramolecular chemistry towards clinical applications. , 2013, Chemical Society reviews.
[28] Stephen Mann,et al. Interfacial assembly of protein–polymer nano-conjugates into stimulus-responsive biomimetic protocells , 2013, Nature Communications.
[29] V. Trezza,et al. Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.
[30] David K Smith,et al. Self-assembling ligands for multivalent nanoscale heparin binding. , 2011, Angewandte Chemie.
[31] Gaurav Sahay,et al. Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[32] M. Nowakowska,et al. Chitosan derivatives as novel potential heparin reversal agents. , 2010, Journal of medicinal chemistry.
[33] Olli Ikkala,et al. Precisely defined protein-polymer conjugates: construction of synthetic DNA binding domains on proteins by using multivalent dendrons. , 2007, ACS nano.
[34] A. Girolami,et al. Heparin-induced thrombocytopenia: a review. , 2006, Seminars in thrombosis and hemostasis.
[35] J. Hardy,et al. High-affinity multivalent DNA binding by using low-molecular-weight dendrons. , 2005, Angewandte Chemie.
[36] S. Hudson,et al. Synthesis and antimicrobial activity of a water-soluble chitosan derivative with a fiber-reactive group. , 2004, Carbohydrate research.
[37] Robert J Linhardt,et al. Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetry. , 2002, European journal of biochemistry.
[38] Trevor Douglas,et al. Host–guest encapsulation of materials by assembled virus protein cages , 1998, Nature.